These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21383697)

  • 21. Co-targeting of IGF1R/mTOR pathway by miR-497 and miR-99a impairs hepatocellular carcinoma development.
    Cheng H; Xue J; Yang S; Chen Y; Wang Y; Zhu Y; Wang X; Kuang D; Ruan Q; Duan Y; Wang G
    Oncotarget; 2017 Jul; 8(29):47984-47997. PubMed ID: 28624790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WJD008, a dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin inhibitor, prevents PI3K signaling and inhibits the proliferation of transformed cells with oncogenic PI3K mutant.
    Li T; Wang J; Wang X; Yang N; Chen SM; Tong LJ; Yang CH; Meng LH; Ding J
    J Pharmacol Exp Ther; 2010 Sep; 334(3):830-8. PubMed ID: 20522531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
    Feng B; Wang R; Chen LB
    Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
    Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
    Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.
    Uesugi A; Kozaki K; Tsuruta T; Furuta M; Morita K; Imoto I; Omura K; Inazawa J
    Cancer Res; 2011 Sep; 71(17):5765-78. PubMed ID: 21795477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
    Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
    Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-99a inhibits insulin-induced proliferation, migration, dedifferentiation, and rapamycin resistance of vascular smooth muscle cells by inhibiting insulin-like growth factor-1 receptor and mammalian target of rapamycin.
    Zhang ZW; Guo RW; Lv JL; Wang XM; Ye JS; Lu NH; Liang X; Yang LX
    Biochem Biophys Res Commun; 2017 Apr; 486(2):414-422. PubMed ID: 28315335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.
    Ischenko I; Camaj P; Seeliger H; Kleespies A; Guba M; De Toni EN; Schwarz B; Graeb C; Eichhorn ME; Jauch KW; Bruns CJ
    Oncogene; 2008 Dec; 27(57):7212-22. PubMed ID: 18794807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delineating v-Src downstream effector pathways in transformed myoblasts.
    Ciuffini L; Castellani L; Salvati E; Galletti S; Falcone G; Alemà S
    Oncogene; 2008 Jan; 27(4):528-39. PubMed ID: 17637741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth.
    Zha X; Hu Z; Ji S; Jin F; Jiang K; Li C; Zhao P; Tu Z; Chen X; Di L; Zhou H; Zhang H
    Cancer Lett; 2015 Apr; 359(1):97-106. PubMed ID: 25578782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis.
    Zha X; Wang F; Wang Y; He S; Jing Y; Wu X; Zhang H
    Cancer Res; 2011 Jan; 71(1):13-8. PubMed ID: 21199794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.
    Lang Q; Ling C
    Biochem Biophys Res Commun; 2012 Sep; 426(2):247-52. PubMed ID: 22940133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of miR-21 by Ras in vivo and its role in tumor growth.
    Frezzetti D; De Menna M; Zoppoli P; Guerra C; Ferraro A; Bello AM; De Luca P; Calabrese C; Fusco A; Ceccarelli M; Zollo M; Barbacid M; Di Lauro R; De Vita G
    Oncogene; 2011 Jan; 30(3):275-86. PubMed ID: 20956945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic Ras-mediated downregulation of Clast1/LR8 is involved in Ras-mediated neoplastic transformation and tumorigenesis in NIH3T3 cells.
    Ryu SH; Kim KH; Kim HB; Kim MH; Kim NH; Kang Y; Hyun JW; Seo HJ; Jun JY; You HJ
    Cancer Sci; 2010 Sep; 101(9):1990-6. PubMed ID: 20550525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3,6-Dihydroxyflavone Suppresses Breast Carcinogenesis by Epigenetically Regulating miR-34a and miR-21.
    Peng X; Chang H; Gu Y; Chen J; Yi L; Xie Q; Zhu J; Zhang Q; Mi M
    Cancer Prev Res (Phila); 2015 Jun; 8(6):509-17. PubMed ID: 25784176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptor protein Crk induces Src-dependent activation of p38 MAPK in regulation of synovial sarcoma cell proliferation.
    Watanabe T; Tsuda M; Tanaka S; Ohba Y; Kawaguchi H; Majima T; Sawa H; Minami A
    Mol Cancer Res; 2009 Sep; 7(9):1582-92. PubMed ID: 19737974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src.
    Oneyama C; Hikita T; Enya K; Dobenecker MW; Saito K; Nada S; Tarakhovsky A; Okada M
    Mol Cell; 2008 May; 30(4):426-36. PubMed ID: 18498747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.
    Sunayama J; Matsuda K; Sato A; Tachibana K; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
    Stem Cells; 2010 Nov; 28(11):1930-9. PubMed ID: 20857497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway.
    Iwaya T; Yokobori T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Sawada G; Takahashi Y; Ishibashi M; Wakabayashi G; Mori M; Mimori K
    Carcinogenesis; 2012 Dec; 33(12):2391-7. PubMed ID: 22983984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.